Prostate cancer is the second leading cause of cancer death among American men. A ground-breaking study, conducted by ...

Nanoparticle therapy brings new hope to prostate cancer patients, offering targeted treatment that improves outcomes with fewer side effects.

A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, ...

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

Prostate cancer is the second leading cause of cancer death among American men.A ground-breaking study , conducted by researchers from the ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Despite the ongoing debate, study finding support retaining the “cancer” designation for patients with Gleason grade group 1 ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Rezum is an advanced technology designed to treat enlarged prostate without surgery or medication. This new method utilises ...

After decades of research, the field of focused ultrasound is exploding with new advances — promising safer, more effective ...

SIGNIFICANT milestone in the health sector has been achieved as Kairuki Hospital introduces High-Intensity Focused Ultrasound ...